Biological Sciences Division
Published December 20, 2012 | Version v1
Patent Open

THERAPEUTICS TO INHIBIT MLL-MENIN INTERACTION FOR TREATING LEUKEMIA

Creators

  • 1. University of Chicago

Contributors

Description

Cell permeable peptides derived from MLL that block the interaction of MLL with menin for the treatment of acute myeloid and acute lymphoid leukemia are disclosed. Small molecules interfere with the interaction of MLL with any of its binding partners.

Files

US20120322742.pdf

Files (650.0 kB)

Name Size Download all
md5:b0bdd8bb2fb9e8d6ca0cfdd68809a00d
650.0 kB Preview Download

Additional details

Identifiers

Patent number
US 201213552126 A
Patent application number
US 2012/0322742 A1
Other
oai:uchicago.tind.io:7897

Dates

Patent filed
2012-07-18

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Medicine